title: [Current status and future prospect of internal medicine treatment for advanced esophageal cancer].
abstract: Esophageal cancer (EC) is one of common malignant tumors, and the incidence and mortality of EC in China rank the first place in the world. Because of the occult onset, the early atypical symptoms, and the lack of effective early diagnostic methods, most of patients are diagnosed at an advanced stage of the disease and lost the chance of surgery. Comprehensive treatment including palliative medical treatment, molecular targeted therapy, immunotherapy and so on is appropriate for these patients. How to choose the chemotherapy regimen and formulate reasonable treatment plan has become a hot spot in clinical research. Molecular targeted drugs have become a new developmental direction in cancer treatment because of their high specificity and antitumor activity, but the effects on esophageal cancer remain controversial. With the development of immune check point blockade treatment, breakthrough has been made in tumor immunotherapy, which has become an important means in cancer comprehensive treatment and shown a good prospect of treatment.
authors.affiliation: The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
authors.forename: F
authors.initials: F
authors.lastname: Wang
authors.affiliation: The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
authors.forename: Q X
authors.initials: QX
authors.lastname: Fan
mesh_terms: D004938:Esophageal Neoplasms; D006801:Humans; D007167:Immunotherapy; D015994:Incidence; D007388:Internal Medicine; D058990:Molecular Targeted Therapy